Internet Pharmaceutical Sites Under Scrutiny
Clinton Administration Proposes Legislation to Regulate Pharmaceutical Websites
WASHINGTON, DC--In response to the increased Internet use to buy medical products, the Clinton Administration has proposed new legislation to regulate the sale of pharmaceuticals over the Internet. The initiative would give the FDA more power to regulate, investigate, and prosecute sites that do not comply with federal and state pharmaceutical sales laws. Online pharmacies would have to demonstrate their compliance to the FDA prior to commencing operations or be subject to sanctions.
The FDA currently has the authority to take legal action; however, the new initiative would give them administrative subpoena authority when investigating potential fraudulent sites. Targeted are sites that sell unapproved or counterfeit drugs, or false "miracle" drugs. Additionally, the proposal creates a $500,000 fine per violation for online selling of prescription drugs to individuals without valid prescriptions.
The Fiscal Year 2001 budget has earmarked $10 million to enhance the FDA's computer technology and fund a public education program regarding the safe purchase of pharmaceutical products on the Internet.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
